Transactions of Managers and Closely Associated Persons

By Alvotech | July 03, 2026, 4:01 PM

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging of (i) 88,940,619 shares and (ii) 7,007,321 depository receipts on shares in Alvotech by Celtic Lux Holdings S.a. r.l. (formerly known as Alvogen Lux Holdings S.a. r.l.). The date of the transactions was June 26, 2026.

Alvotech Investor Relations
Benedikt Stefansson, VP
alvotech.ir@alvotech.com

Attachments

Mentioned In This Article

ALVO

+0.84%

Alvotech

Latest News

2 hours	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
Jul-01	Alvotech further strengthens liquidity by securing term loan facility of $75 million ALVO GlobeNewswire
Jun-22	Transactions of Managers and Closely Associated Persons ALVO -6.89% GlobeNewswire
Jun-18	Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement ALVO GlobeNewswire
Jun-18	Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares ALVO GlobeNewswire
Jun-15	Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement ALVO ALVO -8.73% GlobeNewswire
Jun-15	Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares ALVO ALVO -8.73% GlobeNewswire
Jun-10	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
Jun-08	Alvotech shares jump after FDA accepts Entyvio biosimilar application for review (ALVO) ALVO +19.77% InvestorsHub
Jun-08	Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio ALVO +19.77% GlobeNewswire
Jun-04	Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi and Simponi Aria, and AVT06, a proposed biosimilar to Eylea ALVO +19.11% GlobeNewswire
Jun-03	Main Results of 2026 Annual and Extraordinary General Meeting ALVO GlobeNewswire
Jun-02	Alvotech to present at upcoming investor conferences in June ALVO -6.83% GlobeNewswire
Jun-01	Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland ALVO GlobeNewswire
May-11	Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility ALVO +10.12% GlobeNewswire

Transactions of Managers and Closely Associated Persons

Mentioned In This Article

Latest News

Upgrade your Finviz experience